Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells. | Ann Transl Med | 2022 | 35965805 | PubTator, text mining | PubMed |
| The Galaninergic System: A Target for Cancer Treatment. | Cancers (Basel) | 2022 | 35954419 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation. | Front Immunol | 2022 | 35935998 | PubTator, text mining | PubMed |
| Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms. | Front Immunol | 2022 | 35935969 | PubTator, text mining | PubMed |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. | Science | 2022 | 35926050 | PubTator, text mining | PubMed |
| 15N-Detected TROSY NMR experiments to study large disordered proteins in high-field magnets. | Chem Commun (Camb) | 2022 | 35920752 | PubTator, text mining | PubMed |
| Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma. | Front Oncol | 2022 | 35912218 | PubTator, text mining | PubMed |
| RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R. | Nat Commun | 2022 | 35908044 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+ T Exhausted State to be Associated with Clinical Benefits in Melanoma. | Front Immunol | 2022 | 35903095 | PubTator, text mining | PubMed |
| Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators. | Cells | 2022 | 35892559 | PubTator, text mining | PubMed |
| NFAT1 Orchestrates Spinal Microglial Transcription and Promotes Microglial Proliferation via c-MYC Contributing to Nerve Injury-Induced Neuropathic Pain. | Adv Sci (Weinh) | 2022 | 35892263 | PubTator, text mining | PubMed |
| Multi-Cell-Type Openness-Weighted Association Studies for Trait-Associated Genomic Segments Prioritization. | Genes (Basel) | 2022 | 35886003 | PubTator, text mining | PubMed |
| Research on Potential Network Markers and Signaling Pathways in Type 2 Diabetes Based on Conditional Cell-Specific Network. | Genes (Basel) | 2022 | 35885938 | PubTator, text mining | PubMed |
| Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. | Biomedicines | 2022 | 35884913 | PubTator, text mining | PubMed |
| Store-Operated Ca2+ Entry Is Up-Regulated in Tumour-Infiltrating Lymphocytes from Metastatic Colorectal Cancer Patients. | Cancers (Basel) | 2022 | 35884372 | PubTator, text mining | PubMed |
| Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. | Clin Transl Med | 2022 | 35876041 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Difference in Human Normal and Degenerative Nucleus Pulposus Tissue Profiles and Cellular Interactions. | Front Cell Dev Biol | 2022 | 35874809 | PubTator, text mining | PubMed |
| p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity. | Microbiol Spectr | 2022 | 35867400 | PubTator, text mining | PubMed |
| Calcium Ions Signaling: Targets for Attack and Utilization by Viruses. | Front Microbiol | 2022 | 35859744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=29